$44.5 Million NIMH Grant Bolsters RUCDR Infinite Biologics as Primary Resource for Genomic Research
Piscataway, NJ, June 27, 2013 — RUCDR Infinite Biologics, the world’s largest university-based biorepository, received a $44.5 million Cooperative Agreement award from the National Institute of Mental Health earlier this month to support its NIMH Center for Collaborative Genomics Research on Mental Disorders, which provides services to NIMH-funded scientists engaged in genomic research on mental disorders.
RUCDR Infinite Biologics, which recently completed an $11.4 million expansion and renovation, is located on the Busch Campus of Rutgers, The State University of New Jersey. Continue reading
Study: Wiser Medication Use Could Save U.S. $213B a Year in Avoidable Health Care Costs
Washington, NJ, June 20, 2013 — The Washington Post reported that if doctors and patients used prescription drugs more wisely, they could save the U.S. health care system at least $213 billion a year, by reducing medication overuse, underuse and other flaws in care that cause complications and longer, more-expensive treatments, researchers conclude.
The new findings by the IMS Institute for Healthcare Informatics improve on numerous prior efforts to quantify the dollars wasted on health care. Continue reading
HINJ Testifies Before FDA on Need for Additional 510(k) Premarket Notifications
Silver Spring, MD, June 14, 2013 — HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas on Thursday delivered the following testimony at a meeting of the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) relating to “510(k) Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device.” Continue reading
Choose New Jersey Launches Service Tracking RFPs for Contractors
Trenton, NJ, June 14, 2013 — NJBIZ’s Tom Zanki reports that Choose New Jersey Inc. announced Wednesday the launch of RFP Watch, a daily e-mail service providing subscribers with access to public and private business opportunities throughout New Jersey and neighboring states.
Choose New Jersey, the Princeton-based nonprofit that acts as the state’s corporate recruitment arm, describes the service as a “business intelligence and procurement database.” Continue reading
Human Genome Project Paid Off in $966 Billion Life Sciences Boom
New York, NY, June 12, 2013 — Bloomberg reports that the $14.5 billion investment by the U.S. in the Human Genome Project, completed a decade ago, has paid off more than 60-fold in new jobs, drugs and a rapidly expanding genetics industry, an analysis has found.
The endeavor to map human DNA in its entirety created $966 billion in economic impact and $59 billion in federal tax revenue, according to the study released today by United for Medical Research and Battelle, two research advocacy groups. Continue reading
Seton Hall Law School to Host ‘Managing Counterfeiting Issues In The Pharmaceutical Industry’ June 18
Newark, NJ, June 12, 2013 — The Gibbons Institute of Law, Science & Technology at Seton Hall Law School will present “Managing Counterfeiting Issues in the Pharmaceutical Industry” on Tuesday, June 18 at Seton Hall Laws School in Newark from 5 p.m. to 7 p.m.
Pharmaceutical counterfeiting poses a deadly threat to consumers and harms both the reputation and financial condition of pharmaceutical companies. Continue reading
Christie Administration to Launch Angel Investor Tax Credit July 1
Trenton, NJ, June 12, 2013 — The Christie Administration yesterday announced the Angel Investor Tax Credit Program will launch on July 1, 2013.
The program is a result of the Angel Investor Tax Credit Act, which Governor Christie signed into law in January to spur job creation and growth in New Jersey’s current and next generation of high-skill, high-wage emerging technology industries. Continue reading
Rep. Lance Says Medical Device Tax Repeal ‘Critical to Creating Jobs’ for NJ
Washington, DC, June 11, 2013 — Following a tour and townhall-style meeting at C.R. Bard in Murray Hill last month, U.S. Representative Leonard Lance (NJ-07) said will continue to push for a repeal of the medical device tax and press the Food and Drug Administration to lessen regulatory burdens on the industry, calling it “critical to creating jobs for New Jersey and the Nation.” Continue reading
PhRMA Statement on Sequestration of PDUFA User Fees
Washington, DC, June 10, 2013 — Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President of Scientific and Regulatory Affairs Sascha Haverfield, Ph.D., has issued the following statement:
“PhRMA remains deeply concerned about the impact of sequestration on the Food and Drug Administration’s (FDA) ability to fulfill its critical public health mission by fostering timely patient access to safe and effective new medicines. Continue reading
